Enterprise
Oura Acquires Counsel Health for $625M to Integrate AI Care
The smart ring maker is bringing physician consultations and medical AI directly into its ecosystem as wearable companies race to turn biometric data into clinical services.
Key takeaways
- Oura is acquiring Counsel Health for $625 million to own the AI and physician infrastructure already operating inside its app.
- The medical service costs $159 annually for unlimited AI consultations and physician access, with additional costs for prescriptions and treatment.
- Oura reported preliminary revenue of $1.75 billion for fiscal 2024, up 92% year-over-year, six weeks after postponing a planned IPO.
- Counsel will continue serving enterprise partners without requiring patients to purchase Oura hardware, extending the company's reach.
- WHOOP is pursuing a similar strategy to integrate clinical consultations with wearable biometric data.
Oura moves to own its medical AI infrastructure
Oura announced on November 10 that it will acquire Counsel Health for $625 million in cash, bringing the primary care startup that already operates inside its app fully into the company. The deal, which requires customary closing conditions, is expected to finalize before the end of 2026.
Counsel has provided AI-powered medical consultations paired with licensed physicians inside Oura's app since June. Members receive personalized medical advice based on their health data. Under the acquisition terms, Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer, according to TechCrunch citing Bloomberg.
The acquisition follows Oura's decision to postpone a planned IPO valued at up to $2.2 billion in late September, citing market uncertainty. Alongside the deal announcement, Oura disclosed preliminary revenue of approximately $1.75 billion for the fiscal year ending September 30, representing 92% growth year-over-year, as first reported by The Rundown.
How the medical service works
Oura updated its service terms on October 19, offering members a 30-day trial of the medical AI. The ongoing subscription costs $159 annually for unlimited AI consultations and physician access. While physician visits require no insurance or copays, prescriptions, lab work, treatment, and other services carry additional costs.
Care is delivered through Counsel Medical Group, with certain geographic restrictions. Oura specifies the service is not for emergencies and that AI does not replace clinical judgment. Members must consent to share their ring data with Counsel, and any consultation information sent back to Oura requires explicit user direction.
Counsel's AI tools gather medical histories, search clinical guidelines, review records, and identify potential emergencies. The physician interface combines medical records with health trends from wearable data.
Why it matters
Wearable manufacturers are competing to transform passive health monitoring into active medical care. Oura's strategy is to own both the AI technology and the physician infrastructure rather than rely on partnerships. This vertical integration could allow tighter coordination between health alerts and clinical follow-up, and enable faster iteration on software based on physician feedback.
For Oura, the acquisition creates an additional revenue stream beyond hardware and core membership fees. The company says $76.50 of the annual subscription goes to Counsel Medical Group for physician visits, with the remainder covering platform administration. Members must evaluate whether the added access justifies another annual fee plus potential treatment costs.
The deal also preserves Counsel's enterprise partnerships, which could extend Oura's reach to patients who don't own its hardware. Alagappan confirmed Counsel will continue serving those partners without requiring Oura ring purchases.
Competitor WHOOP is pursuing a parallel strategy. In May, it announced plans for U.S. video consultations with licensed clinicians who can access continuous biometric data and, when available, bloodwork and medical history.
Oura cited survey data showing more than 90% of users believed their ring data improved care, though the company provided no sample size, comparison group, or measured clinical outcomes. Whether ownership produces demonstrably better care than partnership models remains to be proven.
Details of the acquisition were first reported by The Rundown.